期刊文献+

中国圆田螺多糖体外抗乙肝病毒的实验研究 被引量:10

Experimental study on polysaccharide of Cipangopaludina chinensis against HBV in vitro
原文传递
导出
摘要 目的:探讨中国圆田螺多糖(PCC)体外抗乙肝病毒的生物学活性。方法:以HepG2 2.2.15细胞系为体外实验模型。MTT法检测细胞毒性,将不同安全浓度的PCC及阳性对照药物3TC作用于此细胞系,实验同时设不加药物的细胞对照,第9天收集细胞培养上清液。采用ELISA法测定各组细胞培养上清液中HBsAg,HBeAg水平,荧光探针定量PCR检测HBV-DNA含量。结果:PCC在HepG2 2.2.15细胞培养中的TC0为1 g·L-1,TC50>10 g·L-1,对细胞毒性较小。PCC对HepG2 2.2.15细胞HBsAg,HBeAg分泌的IC50分别为0.501,0.401 g·L-1,SI分别为>19.96和>24.94。PCC可以有效抑制HBsAg,HBeAg的分泌,且PCC对HBeAg的抑制效果优于HBsAg。PCC在0.1,1 g·L-1(P<0.05)对HepG2 2.2.15细胞中的HBV-DNA有明显的抑制作用。结论:中国圆田螺多糖具有一定的体外抗HBV活性,且毒性较小,具有良好的应用前景。 Objective: To evaluate the biological activity of polysaccharide of Cipangopaludina chinensis ( PCC ) against HBV in vitro. Method: HepG2 2. 2. 15 cells were taken as the in vitro experimental model, The cell toxicity was observed by MTT. PCC of different safe concentrations and positive control medicine 3TC were added into the cells. Cell control without medicine was set at the same time. Cultural supernatants were collected at 9 d. HBsAg and HBeAg in cultural supernatants were tested by ELISA. The content of HBV-DNA was detected by TaqMan probe fluorescence quantitative PCR. Result: TC0 and TCs0 of PCC in HepG2 2. 2. 15 cell culture were 1 g . L-1 and 〉 t g . L-1, respectively, suggesting low toxicity in cells. ICs0 of PCC in HepG2 2. 2. 15 ceils HBsAg and HBeAg were 0. 501, 0. 401 g . L-1, with SI being 〉 19.96 and 〉24. 94, respectively. PCC could effectively inhibit the secretion of HBsAg and HBeAg, and have a better effect on HBeAg than on HBsAg. PCC had a significant inhibitory effect on HBV-DNA in HepG2 2. 2. 15 cells at concentrations of 0. 1, 1 g . L-1 (P 〈0. 05). Conclusion: PCC has the effect against HBV activity in vitro to some extent, with low toxicity, thereby havinz a zood nrosoect for annlication.
出处 《中国中药杂志》 CAS CSCD 北大核心 2013年第6期879-883,共5页 China Journal of Chinese Materia Medica
基金 安徽省教育厅高校省级自然科学重点研究项目(KJ2008A014)
关键词 多糖 乙型肝炎病毒 中国圆田螺 2 2 15细胞 polysaccharide HBV polysaccharide of Cipangopaludina chinensis 2. 2. 15 cell
  • 相关文献

参考文献8

二级参考文献39

  • 1周静.近年来国内植物多糖生物活性研究进展[J].中草药,1994,25(1):40-44. 被引量:50
  • 2赵勇,张玲.中药免疫调节研究进展[J].中草药,1994,25(11):603-606. 被引量:35
  • 3王贵强 斯崇文.慢性乙型肝炎治疗现状及展望[N].中国医学论坛报30版,2002年4月25日.
  • 4何妮.治疗乙肝病毒的新武器——葡萄糖苷酶抑制衍生物[N].中国医学论坛报,2001年7月14日版.
  • 5峡江.治疗慢性肝炎的新进展[N].中国医学论坛报,2001年11月8日专刊.
  • 6何生松 蔡淑清 罗端德 等.磷甲酸钠治疗慢性乙型肝炎近期疗效观察[N].中国医学论坛报,2000年10月12日专刊.
  • 7Ghany MG,Lau DT,Doo E,et al. Clinical feetures of viral resistance in patients with chronic hepatitis B maintained On longterm lamimdine therapy.Hepatology 2000,32(2) :376A.
  • 8Leung NYW, Lai CL, Chang TT,et al. Three year lamivudine therapy in chronic HBV. J Hepatol 1999;30(suppl) : 59.
  • 9Boni C,Bertoletti A,Penna A,et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis. J Clin Invest 1998,102:968.
  • 10杜罗喜,中国医药工业杂志,1991年,22卷,9期,430页

共引文献198

同被引文献221

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部